High Frequency of Copy Number Variations and Sequence Variants at CYP21A2 Locus: Implication for the Genetic Diagnosis of 21-Hydroxylase Deficiency
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The systematic study of the human genome indicates that the inter-individual variability is greater than expected and it is not only related to sequence polymorphisms but also to gene copy number variants (CNVs). Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency (21OHD) is the most common autosomal recessive disorder with a carrier frequency of 1:25 to 1:10. The gene that encodes 21-hydroxylase enzyme, CYP21A2, is considered to be one of the most polymorphic human genes. Copy number variations, such as deletions, which are severe mutations common in 21OHD patients, or gene duplications, which have been reported as rare events, have also been described. The correct characterization of 21OHD alleles is important for disease carrier detection and genetic counselling METHODOLOGY AND FINDINGS: CYP21A2 genotyping by sequencing has been performed in a random sample of the Spanish population, where 144 individuals recruited from university students and employees of the hospital were studied. The frequency of CYP21A2 mutated alleles in our sample was 15.3% (77.3% were mild mutations, 9% were severe mutations and 13.6% were novel variants). Gene dosage assessment was also performed when CYP21A2 gene duplication was suspected. This analysis showed that 7% of individuals bore a chromosome with a duplicated CYP21A2 gene, where one of the copies was mutated. CONCLUSIONS: As far as we know, the present study has shown the highest frequency of 21OHD carriers reported by a genotyping analysis. In addition, a high frequency of alleles with CYP21A2 duplications, which could be misinterpreted as 21OHD alleles, was found. Moreover, a high frequency of novel genetic variations with an unknown effect on 21-hydroxylase activity was also found. The high frequency of gene duplications, as well as novel variations, should be considered since they have an important involvement in carrier testing and genetic counseling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In NC CAH the estimated residual enzymatic activity of CYP21A2 is about 20 -50% based on in vitro or in silico studies, resulting in a generally mild but highly variable phenotype (212,217,416).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [212]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Long-term health outcomes in adults do not correlate well with the genotype (212).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [212]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397 · cited 1×
“The frequency of CYP21A2 deletions and chimeric CYP21A1P/ CYP21A2 genes found was lower than the 15–20% described by other authors [31,32].”
ResultWedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370
Therrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344 · cited 1×
“. It has been reported that 14% of classic forms and 84% of non-classic forms are missed on the neonatal screening performed during the first days of life”
BackgroundNonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Blanchong, C. A., Zhou, B., Rupert, K. L., Chung, E. K., Jones, K. N., Sotos, J. F., Zipf, W. B., Rennebohm, R. M., & Yu, C. Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.12.2183 · Cited by 187 · cited 1×
“The trimodular organization accounts for only 14% of the chromosomes in population studies [23] and the majority carry two copies of the CYP21A1P pseudogene and one copy of the CYP21A2 gene.”
Background
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Carmina, E., Dewailly, D., Escobar-Morreale, H. F., Kelestimur, F., Moran, C., Oberfield, S., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 201
Finkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192
“The schematic diagram shows a common bimodular RCCX (A); an uncommon bimodular RCCX with an additional copy of CYP21A2 gene linked to the pseudogene XA, and PCR amplification using primer pairs P3S/2R and P3S/3R are positive for duplicated CYP21A2 allele but negative for common RCCX modules (7) (B); a monomodular RCCX…”
MethodCongenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
State of the Art for Genetic Testing of Infertile Men
McLachlan, R. I., & O'Bryan, M. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1925 · Cited by 173
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 161
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 217
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110
Concolino, P., & Costella, A. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0319-y · Cited by 96
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Pignatelli, D., Carvalho, B. L., Palmeiro, A., Barros, A., Guerreiro, S. G., & Macut, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00432 · Cited by 95
Comprehensive analysis of congenital adrenal hyperplasia using long-read sequencing
Liu, Y., Chen, M., Liu, J., Mao, A., Teng, Y., Yan, H., Zhu, H., Li, Z., Liang, D., & Wu, L. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac046 · Cited by 80
Kleinle, S., Lang, R., Fischer, G. F., Vierhapper, H., Waldhauser, F., Födinger, M., & Baumgartner-Parzer, S. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0487 · Cited by 67
“%) of clinically unaffected Spanish individuals to carry such duplicated CYP21A2 genes with a Q318X mutation, whereas this haplotype was at first (6, 7) regarded as a rare one.”
BackgroundMethodInfluentialConcolino, P., Mello, E., Toscano, V., Ameglio, F., Zuppi, C., & Capoluongo, E. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.008 · Cited by 69
Comprehensive Mutation Analysis of the CYP21A2 Gene
Xu, Z., Chen, W., Merke, D. P., & McDonnell, N. B. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.06.001 · Cited by 62
Abulí, A., Boada, M., Rodríguez‐Santiago, B., Coroleu, B., Veiga, A., Armengol, L., Barri, P. N., Jurado, L. A. P., & Estivill, X. (2016) · Human Mutation · doi:10.1002/humu.22989 · Cited by 59
Impact of Molecular Genetics on Congenital Adrenal Hyperplasia Management
Balsamo, A., Baldazzi, L., Menabò, S., & Cicognani, A. (2010) · Sexual Development · doi:10.1159/000315959 · Cited by 54
Cruz, J. N., da Costa, K. S., de Carvalho, T. A. A., & Alencar, N. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1607560 · Cited by 54
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Genes and Pseudogenes: Complexity of the RCCX Locus and Disease
Carrozza, C., Foca, L., De Paolis, E., & Concolino, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709758 · Cited by 37
Molecular diagnosis of steroid 21-hydroxylase deficiency: A practical approach
Arriba, M., & Ezquieta, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.834549 · Cited by 30
Mutation Analysis of the CYP21A2 Gene in the Iranian Population
Rabbani, B., Mahdieh, N., Ashtıani, M. T. H., Larijani, B. A., Akbari, M. T., New, M. I., Parsa, A. A., Schouten, J. P., & Rabbani, A. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0099 · Cited by 32
Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency
Ma, D., Chen, Y., Sun, Y., Yang, B. Y., Cheng, J., Huang, M., Zhang, J., Zhang, J., Hu, P., Lin, Y., et al. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.01.019 · Cited by 29
Prenatal treatment of congenital adrenal hyperplasia-not standard of care
Witchel, S. F., & Miller, W. L. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9508-8 · Cited by 29
“Most individuals have both a CYP21A1P pseudogene and an adjacent CYP21A2 gene on each allele, but normal individuals can have anywhere from 0 to 4 copies of the CYP21A1P pseudogene or the CYP21A2 functional gene on a single allele (Parajes et al. 2008; Kleinle et al. 2009).”
BackgroundChallenges in the diagnosis and management of disorders of sex development
KUTNEY, K. A., Konczal, L. L., Kaminski, B. A., & Uli, N. K. (2016) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21147 · Cited by 31
Kharrat, M., Riahi, A., Maazoul, F., Mʼrad, R., & Chaabouni, H. (2011) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181f24807 · Cited by 25
Su, L., Yin, X., Cheng, J., Cai, Y., Wu, D., Feng, Z., & Liu, L. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.039 · Cited by 25
Carvalho, B., Marques, C. J., Silva, R. S., Fontoura, M., Carvalho, D. M., & Carvalho, F. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1108-1419 · Cited by 27
Identification of copy number variation-driven genes for liver cancer via bioinformatics analysis
Lu, X., Ye, K., Zou, K., & Chen, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3425 · Cited by 24
Cantürk, C., Baade, U., Salazar, R., Storm, N., Pörtner, R., & Höppner, W. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.156893 · Cited by 23
Lekarev, O., Tafuri, K., Lane, A. H., Zhu, G., Nakamoto, J. M., Buller-Burckle, A. M., Wilson, T. A., & New, M. I. (2013) · Journal of Perinatology · doi:10.1038/jp.2012.5 · Cited by 21
Genes, pseudogenes and like genes: The case of 21-hydroxylase in Italian population
Concolino, P., Mello, E., Minucci, A., Giardina, B., & Capoluongo, E. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.019 · Cited by 21
CNVs and genetic medicine (excitement and consequences of a rediscovery)
Beckmann, J. S., Sharp, A. J., & Antonarakis, S. E. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184687 · Cited by 24
Greene, C. N., Cordovado, S. K., Turner, D. P., Keong, L. M., Shulman, D., & Mueller, P. W. (2014) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2014.07.002 · Cited by 19
Jang, J., Jin, D., Kim, J., Tan, H.-K., Kim, J.-W., Lee, S., Ki, C., & Park, H. (2011) · PubMed · Cited by 21
Doleschall, M., Luczay, A., Klara, K., Hadzsiev, K., Erhardt, É., Szilágyi, Á., Doleschall, Z., Németh, K., Török, D., Prohászka, Z., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.38 · Cited by 21
Chen, W., Xu, Z., Nishitani, M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2012) · Human Genetics · doi:10.1007/s00439-012-1217-8 · Cited by 18
Kang, Y., Nam, S.-H., Park, K., Kim, Y., Kim, J., Lee, E., Ko, J. M., Lee, K., & Park, I. H. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2409-6 · Cited by 17
Tremmel, R., Klein, K., Battke, F., Fehr, S., Winter, S., Scheurenbrand, T., Schaeffeler, E., Biskup, S., Schwab, M. G., & Zanger, U. M. (2019) · Human Genetics · doi:10.1007/s00439-019-02093-7 · Cited by 17
Toraman, B., Ökten, A., Kalay, E., Karagüzel, G., Dinçer, T., Açıkgöz, E. G., & Karagüzel, A. (2013) · Gene · doi:10.1016/j.gene.2012.10.059 · Cited by 14
“3% (Asanuma et al., 1999; Bas et al., 2009; Campos et al., 2009; Dolzan et al., 2005; Dracopoulou-Vabouli et al., 2001; Finkielstain et al., 2011; Friaes et al., 2006; Kapelari et al., 1999; Kharrat et al., 2004; Koppens et al., 2000; Krone et al., 2000; Lako et al., 1999; Lee et al., 2008; Parajes et al., 2008; Rabba…”
BackgroundResultInfluentialYoo, Y., Chang, M. S., Lee, J., Cho, S. Y., Park, S. W., Jin, D., & Park, H. (2013) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2013.18.3.128 · Cited by 14
Analysis of CYP21A1P and the duplicated CYP21A2 genes
Tsai, L., & Lee, H.-H. (2012) · Gene · doi:10.1016/j.gene.2012.06.045 · Cited by 15
Dubey, S., Tardy, V., Chowdhury, M. R., Gupta, N., Jain, V., Deka, D., Sharma, P., Morel, Y., & Kabra, M. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_329_16 · Cited by 16
Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia
Lee, H.-H. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.030 · Cited by 12
Lan, T., Jin, W., Chen, K., Zhang, J., Chen, X., & Yao, H. J. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1472516 · Cited by 13
Santomé Collazo, J. L., Cirujano Segura, A., Ferreiro Fernández, B., Casado Fúnez, C., Muñoz-Pacheco, R., & Ezquieta Zubicaray, B. (2010) · Medicina Clínica · doi:10.1016/j.medcli.2009.11.039 · Cited by 10
Concolino, P. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050291 · Cited by 10
Fanis, P., Skordis, N., Toumba, M., Picolos, M. K., Tanteles, G. A., Neocleous, V., & Phylactou, L. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1156616 · Cited by 8
Shammas, C., Byrou, S., Phelan, M. M., Toumba, M., Stylianou, C., Skordis, N., Neocleous, V., & Phylactou, L. A. (2016) · HORMONES · doi:10.14310/horm.2002.1651 · Cited by 7
Nan, M. N., Roig, R., Martínez, S., Rives, J., Urgell, E., Espinós, J. J., Tirado-Capistros, M., Carreras, G., Aulinas, A., Webb, S. M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061183 · Cited by 7
Genetic characterization of a large cohort of Argentine 21‐hydroxylase Deficiency
Fernández, C. S., Taboas, M., Bruque, C. D., Benavides‐Mori, B., Belli, S., Stivel, M., Oneto, A., Pasqualini, T., Delea, M., Espeche, L. D., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14190 · Cited by 7
Concolino, P. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05379-6 · Cited by 6
Blaskó, B., Bánlaki, Z., Gyapay, G., Pozsonyi, É., Sasvári‐Székely, M., Rajczy, K., Füst, G., & Szilágyi, Á. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.033 · Cited by 6
Fylaktou, I., Mertzanian, A., Farakla, I., Gryparis, A., Vasilakis, I. A., Binou, M., Charmandari, E., Kanaka‐Gantenbein, C., & Sertedaki, A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46100635 · Cited by 6
Ji, W., Li, J., & Liu, J. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.01.010 · Cited by 6
Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
Carşote, M., Gheorghe, A.-M., Nistor, C., Trandafir, A.-I., Sima, O.-C., Cucu, A.-P., Ciuche, A., Petrova, E. N., & Ghemigian, A. M. (2023) · Biomedicines · doi:10.3390/biomedicines11113081 · Cited by 8
Malíková, J., Votava, F., Vrzalová, Z., Lebl, J., & Cinek, O. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04358.x · Cited by 7
Lack of genotypephenotype correlation in congenital adrenal hyperplasia due to a CYP21A2-like gene
Leccese, A., Longo, V., Dimatteo, C., Girolamo, G. D., Trunzo, R., D’Andrea, G., Bafunno, V., Margaglione, M., & Santacroce, R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.009 · Cited by 5
Claps, A., Kolomenski, J. E., Fernández, F., Macchiaroli, N., Ingravidi, M. L., Delea, M., Fernández, C., Castro, T., Laiseca, J., Kamenetzky, L., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-03799-7 · Cited by 3
Genomic complexity and clinical significance of the RCCX locus
Shiryagin, V. V., Deviatkin, A. A., Fateev, O. D., Petriaikina, E. S., Bogdanov, V. P., Antysheva, Z., Volchkov, P., Yudin, S. M., Woroncow, M. V., & Skvortsova, V. I. (2024) · PeerJ · doi:10.7717/peerj.18243 · Cited by 3
2+0 CYP21A2 deletion carrier — a limitation of the genetic testing and counseling: A case report
Na, X., Song, X., Wang, X., Qin, S., He, G., Sun, L., & Chen, X. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i23.6789 · Cited by 3
Баранник, А. П., Koltunova, A. A., Ozolinya, L. A., Lavrova, N. V., Шилов, И. А., Guzov, I. I., & Patrushev, L. I. (2010) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162010030076 · Cited by 4
Consejo genético en la hiperplasia suprarrenal congénita por déficit de 21-hidroxilasa
Fernández, B. H., Martín, M. B. R., Arnao, M. D. R., & Zubicaray, B. E. (2011) · Anales de Pediatría · doi:10.1016/j.anpedi.2011.08.004 · Cited by 4
Genetics and Pathophysiology of Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_5 · Cited by 4
Xia, Y., Yu, F., Bai, Y., Jiang, L., Shi, P., Jiang, Z., & Kong, X. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03414-4 · Cited by 2
Geographical Endocrinology of Genetic Steroid Disorders
Reisch, N., & Kuhnle, U. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00029-6 · Cited by 2
Ionova, T. A., & Tyulpakov, A. N. (2014) · Problems of Endocrinology · doi:10.14341/probl201460323-29 · Cited by 2
Molecular Genetics of 21‐Hydroxylase Deficiency
Parajes, S., & Krone, N. P. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0023845 · Cited by 2
Self-citationPignatelli, D., & Pereira, S. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_2 · Cited by 1
Dubey, S., Saxena, R., Kohli, S., Jaswal, H., Rawat, A., Singh, K., Bijarnia‐Mahay, S., Arora, V., Maitra, A., Saravana, C., et al. (2026) · The Indian Journal of Pediatrics · doi:10.1007/s12098-025-05918-8 · Cited by 2
Genetics of Congenital Adrenal Hyperplasia
Krone, N. P. (2022) · doi:10.1093/med/9780198870197.003.0104 · Cited by 1
Dubey, S., Saxena, R., Puri, R. D., & Verma, I. C. (2022) · Indian Pediatrics Case Reports · doi:10.4103/ipcares.ipcares_211_21 · Cited by 1
Genotype in the diagnosis of 21-hydroxylase deficiency: who should undergo CYP21A2 analysis?
Cavarzere, P., Vincenzi, M., Teofoli, F., Gaudino, R., Lauriola, S., Maines, E., Camilot, M., & Antoniazzi, F. (2013) · PubMed · doi:10.3275/9096 · Cited by 1
Keene, S. A. (2013) · International Society of Hair Restoration Surgery · doi:10.33589/23.3.0077 · Cited by 1
Novità nella diagnosi genetica di iperplasia surrenale congenita da deficit di 21-idrossilasi
Menabò, S. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00838-z · Cited by 1
Congenital Adrenal Hyperplasia – The Main Effect of 21-Hydroxylase Deficiency
Carvalho, B., Carvalho, F., & Carvalho, D. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.107092 · Cited by 1
Molecular Genetics of Congenital Adrenal Hyperplasia
Parajes, S., & Krone, N. P. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0023590 · Cited by 1
Self-citationAnálise de genes moduladores do fenótipo da forma não clássica da deficiência da 21-hidroxilase
Moura, V. O. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2011.tde-25082011-153332
Problems of neonatal screening on congenital adrenal hyperplasia
Zelinska, N., Погадаєва, Н. Л., Вікторівна, Г. Є., Ніфонтова, Л. В., & Орлова, Т. О. (2013) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.2(43).2013.77677
Knowing what to charge and documenting your worth.
Sautter, E. K. (1992) · PubMed
Adrenal Glands - The Current Stage and New Perspectives of Diseases and Treatment
Păun, D. L., Cianci, P., & Restini, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102209 · Cited by 1
Geographical endocrinology of genetic steroid disorders
Reisch, N., & Kuhnle, U. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00024-1
A review on Congenital Adrenal Hyperplasia andits management
Toms, C., Fathima, B., Neethu, R., & Reji, A. (2024) · International Journal of Advanced Research in Biological Sciences (IJARBS) · doi:10.22192/ijarbs.2024.11.06.002 · Cited by 1
Stanchev, P. E., Dimitrova, M., Makakova, D. R., & Tilov, B. G. (2024) · Medicina · doi:10.3390/medicina60122010
Molavi, N., Aghaei, S., Hoseinzadeh, M., Khanahmad, H., Hashemipour, M., & Tabatabaiefar, M. A. (2025) · Current Genetic Medicine Reports · doi:10.1007/s40142-025-00218-1
Fylaktou, I., Tsinopoulou, V. R., Sertedaki, A., Kanaka‐Gantenbein, C., & Galli‐Τsinopoulou, A. (2025) · Case Reports in Endocrinology · doi:10.1155/crie/1599576
A Two-Step LC-MS/MS method to differentiate 21OHD and PORD in Screen-Positive newborns
Nakatani, H., Watanabe, K., Tsuji‐Hosokawa, A., Sutani, A., Saito, Y., Kirino, S., Yamano, H., Orimoto, R., Gau, M., Yogi, A., et al. (2026) · Endocrine · doi:10.1007/s12020-026-04573-z
Szklarz, M., Wołos-Kłosowicz, K., Szulc, J., Górny, J. M., & Matuszewski, W. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00364-8
Metadata
- Authors
- Parajes, S., Quinteiro, C., Domínguez, F., & Loidi, L.
- Affiliations
- Fundación Pública Galega de Medicina Xenómica (ES)
- Corresponding author
- Loidi, Lourdes
- ORCID
- Loidi, Lourdes
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-05-14
- Volume
- 3
- Issue
- 5
- Pages
- e2138
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2364643
- OpenAlex
- W2025491887
- Cited by
- 87
- References
- 40
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 3 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 3 · 2015: 2 · 2014: 6 · 2013: 8 · 2012: 8
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Repositorio institucional da Universidade de Santiago de Compostela (University of Santiago de Compostela) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- 21-hydroxylase deficiency, congenital adrenal hyperplasia, CYP21A2, copy number variation, gene duplication, genetic variants, carrier frequency, carrier detection, genetic counseling, novel variants, Spanish population
- MeSH terms
- Adrenal Hyperplasia, Congenital, Alleles, Genetic Counseling, Haplotypes, Genetic Carrier Screening, Humans, Steroid 21-Hydroxylase, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.